The most popular and effective FDA-approved weight loss shots are: Ozempic (semaglutide) Weekly injection Wegovy (semaglutide, higher dose) Weekly injection Mounjaro (tirzepatide) Weekly dual-agonist injection Zepbound (tirzepatide) Specifically FDA-approved for weight management Other prescription and off-label injectables include Saxenda (liraglutide) and B12/Lipo shots, but the GLP-1/GIP medications above deliver the most dramatic, research-backed results
Despite the potential for facial changes, Ozempic remains a commonly prescribed medication for managing blood sugar levels in type 2 diabetes patients
Mounjaro can cause several short-term side effects
Some studies suggest small benefits in selected groups, while others show little or no effect
For some women, these changes are temporary and improve as the body adjusts
As a GLP-1 receptor agonist, it activates the same receptor class targeted by naturally occurring incretins, triggering downstream effects on insulin release and satiety signaling